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Prognosis of trochanteric pain
in primary care
ABSTRACT
Background
Trochanteric pain is the second most important
diagnosis of hip problems presenting in primary care,
but its incidence and prognosis in this context is
largely unknown.
Aim
To determine the 1- and 5-year prognoses of
trochanteric pain and the predictive variables for
consistent complaints.
Design of the study
Retrospective cohort study.
Setting
One hundred and sixty-four patients (mean age =
55 years, 80% female) with incidental trochanteric pain
in the years 1996 or 2000 were asked in 2001 for past
and present symptoms of trochanteric pain.
Therapeutic interventions, demographic factors and
comorbidity were also investigated.
Method
The databases of 39 GPs were screened in order to
identify all incident cases with a suspicion of
trochanteric pain in the years 1996 or 2000. These
cases were sent a questionnaire.
Results
The incidence of trochanteric pain in primary care is
1.8 patients per 1000 per year. After 1 year at least
36% still suffered from trochanteric pain, and after 
5 years this was 29%. Patients with osteoarthritis (OA)
in the lower limbs had a 4.8-fold risk of persistent
symptoms after 1 year, as compared to patients
without OA. Patients who had received a corticosteroid
injection had a 2.7-fold chance of recovery after 
5 years, as compared with patients who had not
received an injection.
Conclusion
Trochanteric pain is shown to be a chronic disease in a
substantial number of patients. The disorder is
associated with much impairment when conducting
daily activities.
Keywords
bursitis; cohort studies; osteoarthritis; primary care;
trochanter; trochanteric pain. 
INTRODUCTION
Trochanteric pain, also known as trochanteric
bursitis or pseudotrochanteric bursitis, is a
frequently occurring problem. The pain experienced
by 10–20% of all patients with hip problems
presenting in primary care can be attributed to
trochanteric pain.1
In 1979, Little described trochanteric pain as pain
at the lateral side of the upper thigh, often with
radiation to the knee.2 Although it has been attributed
to trochanteric bursitis and/or tendinitis, one study
reported that sonographic effusion of the bursa was
seldom found; effusion around the trochanteric
tendons, however, was more often present than in
other patients with hip pain.3
Trochanteric pain has been described as a solitary
syndrome that can occur as a result of trauma or as
a comorbid condition in patients with lower back
pain or osteoarthritis (OA) of the hip.4–11 Some authors
have even described trochanteric pain as one of the
first symptoms in developing hip OA.7,8
In order to gain more insight into trochanteric pain,
we performed a retrospective cohort study in general
practice, focusing on the 1- and 5-year prognosis.
In this article we aimed to address the following
questions:
• What is the incidence of trochanteric pain in
general practice?
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• What is the impact of trochanteric pain on daily
activities?
• What therapy is given?
• What is the prognosis of trochanteric pain after 1
and 5 years?
• What variables might predict the prognosis?
METHOD
Sample identification and selection
GPs using electronic medical databases were
approached in 2001 for participation in the study.
Patients aged 18 years and older who presented to
their GP in 1996 or 2000 with pain at the region of
the greater trochanter were identified. The
identification of these patients was done in a
sensitive search in the electronic medical
databases using the keywords ‘troch*’ or ‘pain*’
and ‘hip*’. The medical records of these patients
were read, and they were identified as possible
incident cases if they had consulted their GP for the
first time in 2 years with this symptom. Only
patients who confirmed by questionnaire that they
had suffered from pain at the lateral side of the
upper leg were considered incident cases with
trochanteric pain.
The patients with trochanteric pain in 1996 were
asked for the present condition of their symptoms.
These data were used for the prognosis after 
5 years. The data from patients with trochanteric
pain in 2000 were used for the 1 year follow-up,
subdivided into four groups: those presenting from
January to March 2000 for the 16-month follow-up,
those from April to June for the 13-month follow-
up, from July to September for the 10-month
follow-up, and finally, those from October to
December 2000 for the 7-month follow-up.
How this fits in
Trochanteric pain is a common problem in general
practice. The incidence of trochanteric pain in
primary care is 1.8 per 1000 patients per year. In
the majority of cases it is a prolonged, chronic
disease, and causes substantial impairment of daily
activities.
Figure 1.
Flow-chart of patients and
responders.
Patients with
trochanteric pain
n = 164
Patients with
pain not in region of
greater trochanter
n = 23
Electronic search for
persons with suspicion
of trochanteric pain
No response
n = 158
Responded to
questionnaire 
n = 187
Questionnaire sent
n = 345
A Lievense, S Bierma-Zeinstra, B Schouten, et al
Questionnaire
The questionnaire covered patient characteristics
(demographic data, daily activities and comorbidity),
and various characteristics of the trochanteric pain
(past and present symptoms, localisation, pain
severity [Visual Analogue Scale {VAS}, 0–100] and
type of therapy). 
The present quality of life was assessed with the
EuroQol (0 = worst possible quality of life, 1 = best
possible quality of life).12 The present functional
disability due to the trochanteric pain was assessed
with the WOMAC (Western Ontario and McMaster)
osteoarthritis index.13 This index is used to assess
disability due to arthritis of the hip or knee. It has three
discrete domains — pain (five questions, possible
subscale score 0–20), stiffness (two questions, 0–8)
and physical functioning (17 questions, 0–68) — and
has a minimum score of 0 (best score) and a
maximum score of 96 (worst score).
Data analysis
We investigated the percentage of patients who still
had symptoms of trochanteric pain in 2001
(observed values). In a sensitivity analysis we
assessed whether these figures would change due to
potential selective non-response (expected values).
In the first analysis we assumed that all non-
responders did have trochanteric pain at baseline
and were free of trochanteric pain at the time of
investigation (best case scenario). In the second
analysis we assumed them to still suffer from
trochanteric pain at the end of the follow-up (worst
case scenario).
Left and right censoring. There were only two time
measurements for each patient: time of diagnosis
and that of the follow-up investigation. This implies
that the data of a specified time are based only on
that particular subgroup of patients. For example, for
patients with a follow-up of 13 months there is no
data on their situation at 7, 10, 16 or 60 months, so
if someone has recovered by 13 months, she/he
could already have recovered by the 7- or 10-month
stage; likewise, if not recovered at that time, she/he
could have been recovered at 16 or 60 months. This
‘left and right censoring’ we corrected by analysing
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Identified Non-
patients responders Responders Cases
Number 345 158 187 164
Mean age in years (SD) 55.3 (15.4) 54.4 (17.4) 56.0 (13.5) 55.4 (13.5)
Females (%) 75 69 79.9 79.9
Arthrosis on lower limbs, 48 58
or lower back pain (%)
SD = standard deviation.
Table 1. Characteristics of all identified patients.
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Baseline Follow-up
Mean age in years (SD) 55.4 (13.5)
Females (%) 79.9 79.9
Localisation
Right (%) 40 40
Bilateral (%) 23 23
Body Mass Index
Overweight (BMI 25–30) (%) a 35
Obese (BMI >30) (%) a 15
Hip osteoarthritis (%) a 24
Knee osteoarthritis (%) a 16
Lower back pain (%) a 14
aDue to study design, reliable data at baseline for BMI and co-morbidity is unavailable.
SD = standard deviation.
Table 2. Characteristics of patients with trochanteric pain
(n = 164).
our data with the SAS program PROC LIFE REG
(version 6.12).
Predictive variables. Variables that might have
predicted improvement such as sex, duration of
symptoms, body mass index (BMI) and co-morbidity
were evaluated using the binary logistic regression
mode in SPSS. Variables with a P-value of 0.20 or
less in the univariate analysis were considered in the
backward stepwise multivariate model. Variables
with a P-value of 0.10 or less in the multivariate
model were left in the model. 
RESULTS
Incidence
Forty-one GPs in the southwest region of the
Netherlands were approached, and 39 were willing to
participate. A total of 95 297 persons were registered
with these GPs.
Three hundred and forty-five patients with a
suspicion of trochanteric pain were identified and
sent a questionnaire, of whom 187 (54%) replied. Of
these responders, 164 (88%) met our criteria of
trochanteric pain — that is, patients ≥18 years of age
with pain in the region of the greater trochanter
(cases). The remaining 23 patients reported pain
symptoms in the lower back, groin, buttocks or knees
and not in the region of the greater trochanter. Figure
1 shows the flowchart of the patients and responders. 
There were no statistically significant differences
between sex and age between the non-responders,
responders and cases. Also, no statistical differences
were found for comorbidity between the responders
and the cases (Table 1). 
The incidence of trochanteric pain registered by the
GPs in this population is 1.8 per 1000 patients per year.
Patient characteristics and impact of
trochanteric pain
Of the 164 cases 80% were female and the mean
age at diagnosis was 55.4 years (range = 21–87
years). Table 2 details other patient characteristics.
Of those working, about 34% were ‘very much
troubled’ during work-related activities, and about a
quarter of them had a history of sick leave due to the
trochanteric pain. Roughly 40% of the patients were
disturbed during sleep. Of the 60% of patients who
participated in sport, 54% were ‘greatly impaired’
during their sporting activities.
The mean VAS score for hip pain in patients still
suffering from trochanteric pain at follow-up was
46.0 and their mean total WOMAC score was 36.5.
The mean total WOMAC score for those recovered
was 11.2.
The mean EuroQol score for those with prolonged
symptoms was 0.97 and for those recovered 0.99.
With symptoms Without symptoms
at follow-up at follow-up (P-value) 
Pain (VAS 0–100) 46.0 4.4 <0.0001
WOMAC pain (0–20) 8.6 2.3 <0.0001
WOMAC function (0–68) 25.0 7.6 <0.0001
WOMAC stiffness (0–8) 3.1 1.3 <0.0001
WOMAC total (0–96) 36.5 11.2 <0.0001
EuroQol 0.970 0.992 0.024
State of health (VAS 0–100) 68.5 78.6 0.008
WOMAC = Western Ontario and McMaster osteoarthritis index. VAS = Visual Analogue Scale.
Table 3. Pain and quality-of-life scores at follow-up for those
with greater trochanteric pain symptoms (n = 116) and those
without (n = 48).
The state of health assessed with the VAS was 68.5
for those with symptoms at follow-up, and 78.6 for
those recovered (Table 3).
Therapy
Fifty-five per cent of patients were treated by their
GP or specialist with medication (paracetamol, non-
steroidal anti-inflammatory drugs [NSAIDs] and 52%
of these patients mentioned a temporary
improvement. Of the cases, 37% were injected in the
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region of the greater trochanter with corticosteroids
(66% with improvement).
A third (35%) of the patients were only treated by
their GP. Of these, 53% received paracetamol or
NSAIDs (48% with improvement) and 34% were
injected (60% with improvement).
Half (52%) of the patients in the study received
physiotherapy (two-thirds of whom mentioned
improvement). A third (36%) of the cases attended
hospital, where therapy consisted of administration
of paracetamol or NSAIDs (36%), or a local
corticosteroid injection (34%). Three out of the five
patients who received an operative treatment
reported a reduction in pain.
Prognosis
At the 1-year follow-up stage, 76% of the responders
still suffered from trochanteric pain; at 5 years this
figure stood at 63%.
In the best-case scenario (all non-responders were
cured at the time of investigation) at 1-year follow-up,
36% still had trochanteric pain and at 5 years, 29% did.
In the worst-case scenario (all non-responders
were not cured at the time of investigation), these
percentages changed to 84% and 83%
respectively. 
In the best-fitted analysis (PROC LIFE REG SAS),
78% of the responders had symptoms at 1-year
follow-up and 60% at 5-year follow-up. Observed
and expected values are shown in Figure 2.
Predictive variables
For the prognosis at 1 year, there were two variables
that predicted sustained symptoms of trochanteric
pain; duration of symptoms before the patient
visited the GP (more versus less than 1 week) (odds
ratio [OR] = 4.9, 90% confidence interval [CI] = 1.8
to 13.2) and the presence of OA in the lower limb(s)
at follow-up (OR = 4.8 [CI = 1.2 to 18.5]). In this
model, age and sex were considered as
confounders (Table 4).
Patients developing OA did not receive
corticosteroid injections more or less often when
compared to patients not developing the disease (χ2
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Figure 2. Percentage of
patients with symptoms
of trochanteric pain at
follow-up (%). 
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1-year follow-up 5-year follow-up
Variables Univariate OR (P-value) Multivariate OR (90% CI) Univariate OR (P-value) Multivariate OR (90% CI)
Age (continuous) 1.02 (0.30) 1.01 (0.97 to 1.04) 1.00 (0.95) 1.00 (0.96 to 1.04)
Sex (male/female) 1.75 (0.41) 1.39 (0.41 to 4.77) 1.23 (0.74) 0.78 (0.25 to 2.38)
Bilateral symptoms (-/+) 1.03 (0.96) 2.32 (0.19) 2.35 (0.66 to 8.35)
BMI 
Normal (<25) 0.55 (0.21) a
Overweight (25–30) 2.32 (0.13) 2.38 (0.81 to 6.98) a
Obese (>30) 0.83 (0.77) a
Level of education
Low (primary school) 2.98 (0.07) 1.73 (0.31)
Normal (secondary school) 0.32 (0.03) 0.96 (0.94)
High (higher education) 1.33 (0.68) 0.42 (0.19) 0.38 (0.11 to 1.33)
Duration of symptomsb 5.53 (0.003) 4.88 (1.81 to 13.16) 4.50 (0.10) 5.29 (1.05 to 26.57)
Analgesics (-/+) 1.68 (0.27) 0.63 (0.37)
Corticosteroid injection (-/+) 1.24 (0.66) 0.45 (0.15) 0.37 (0.13 to 1.00)
Arthrosis lower extremities (-/+) 4.26 (0.03) 4.77 (1.23 to 18.50) a
Lower back symptoms (-/+) 4.19 (0.18) 2.70 (0.42 to 17.52) a
aData collected at the 5-year follow-up is likely to have changed over time and cannot be used as a determinant. bBefore visit to the GP (less than 1 week/
1 week or more). OR = odds ratio.
Table 4. Possible determinants for prolonged complaints of trochanteric pain (univariate and multivariate
analyses).
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= 1.43, P = 0.71). No statistically significant
differences were found in specific symptoms at first
presentation, such as pain located only at the greater
trochanter, or occurrence of the pain by applying
pressure (χ2 = 1.43 and 0.18 respectively, P = 0.71
and 0.33, respectively). In this model, age, sex, BMI,
use of analgesics, or consultancy of physiotherapy
all showed no significant relationship with the
prognosis of trochanteric pain. For the long-term
prognosis at 5 years there were two variables that
predicted sustained symptoms of trochanteric pain:
duration of symptoms before the patient visited the
GP (more versus less than 1 week) (OR = 5.3 [CI =
1.1 to 26.6]); and having had a corticosteroid
injection (OR = 0.4 [CI = 0.1 to 1.0]). In this model,
age and sex were considered confounders.
DISCUSSION
Summary of main findings
The incidence of trochanteric pain in primary care is
1.8 patients per 1000 per year. In this study, after
1 year 76% of the responders still suffered from
trochanteric pain, and after 5 years approximately
63% did. Due to possible selection bias, these
figures would probably be lower in reality, but not
lower than 36% and 29%, respectively.
Predictors associated with improvement within
1 year were duration of symptoms at the first visit to
the GP and the absence of osteoarthritis in the lower
limbs. Again, the duration of symptoms before the
first visit to the GP, as well as having had a
corticosteroid injection, were predictive for
improvement within 5 years.
The strengths and limitations of this study
This study is vulnerable to different biases. The first
is selection bias. This may be a result of the high
number of non-responders (46%), and it is probable
that patients with sustained symptoms were more
likely to return the questionnaire. We were able to
correct for this kind of bias in the calculation of the
prognosis of trochanteric pain (best/worst-case
scenario). Likewise, it could be that patients without
symptoms at the time of the investigation did not
return the questionnaire. Therefore, we expect that
the real percentage with sustained symptoms is
lower than observed, and will approximate those
from the best-case scenario.
For the calculation of the incidence of trochanteric
pain, however, the data are likely to be influenced by
this selection bias. That is why we chose not
extrapolate the 12% of patients who were
inaccurately selected with pain located elsewhere to
the non-responders group, but instead to calculate
the incidence directly from the patients with
trochanteric pain as reported by the GP.
The impact of trochanteric pain seems to be
substantial; about 30–40% of the patients were
impaired in their daily activities. However, these data
are also prone to selection bias, because it is
probable that the patients with sustained symptoms
were more likely to return the questionnaire.
Moreover, these data are also prone to a second type
of bias introduced; the so-called recall bias (historical
information reported by the participants is known to
be inaccurate).
The third type of bias in this study is the bias by
indication. An important finding of this study is that
patients who received a corticosteroid injection in the
region of the greater trochanter showed a better
prognosis of their hip problems after 5 years. There
might have been bias by indication; perhaps only
patients with a lot of pain received an injection. Due
to the retrospective character of this study, we were
not able to correct for this potential confounder.
However, assuming that the more severe cases have
a worse prognosis, but also receive an injection
earlier, this study gives an indication that
corticosteroid injections are more effective than other
treatments in trochanteric pain.
To look for other potential biases by indication, we
analysed whether there were variables that might
influence the GP to chose to give an injection. The
only two variables found were pain elicited when the
patient lay on the affected side, and the
development of lower back pain at the time of
follow-up. However, these variables do not
significantly influence the model. 
Finally, our results suggest that patients with OA
had a higher risk of persistent symptoms after
1 year, compared to patients without OA. This
finding may be biased because the greater
trochanter is one of the sites to which hip or knee
OA can refer to.14
As we only had information from the
questionnaire, we did not have objective
information about the condition of the patients. The
data on OA were collected at the end of the follow-
up period, and not when the symptoms of
trochanteric pain began, therefore confusion
between cause and consequence is possible.
Nonetheless, we think that data on OA would not
have changed much and would be fairly stable over
a period of 1 year. Hence, we used these data in the
model for the 1-year follow-up, but not for the 5-
year follow-up.
Comparison with existing literature
Prognosis. This is the first study on the long-term
prognosis of trochanteric pain. There are only a few
case series available of patients receiving one type
of intervention, but the longest follow-up time
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reported was 2 years. In that study a recovery rate
of about 90% was reported.5 A different study
reported on a follow-up after surgery of a maximum
period of 60 months.15 These highly selected
patients in secondary care are not comparable with
our population in primary care. 
Therapy. In our study population, 37% of patient
received corticosteroid injection(s), and about 66%
reported an improvement. This is comparable with
the outcome of a case series in which about 61% of
the patients had improved 6 months after local
injection of corticosteroid and lidocaine.16
The improvement found in our study, however,
differs from earlier case series in which all patients
reported improvement after local corticosteroid
injection(s).5,17 This discrepancy may be due to pre-
selection of the patients (outpatient clinic) or the
previously mentioned selection bias.
Implications for future research or clinical
practice
These data show that trochanteric pain is a
prolonged chronic disease in a substantial number of
patients. The disorder is associated with great
impairment in daily activities.
A trial comparing oral medication (analgesics) with
corticosteroid injection is needed to investigate
common and promising interventions in primary care
for patients with trochanteric pain.
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